↓ Skip to main content

Losigamone add-on therapy for focal epilepsy

Overview of attention for article published in Cochrane database of systematic reviews, December 2019
Altmetric Badge

Mentioned by

facebook
2 Facebook pages

Citations

dimensions_citation
1 Dimensions
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Losigamone add-on therapy for focal epilepsy
Published in
Cochrane database of systematic reviews, December 2019
DOI 10.1002/14651858.cd009324.pub5
Pubmed ID
Authors

Hongchang Chen, Honghu He, Yousheng Xiao, Man Luo, Hongye Luo, Jin Wang

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 March 2020.
All research outputs
#12,180,013
of 15,323,046 outputs
Outputs from Cochrane database of systematic reviews
#10,238
of 11,168 outputs
Outputs of similar age
#188,585
of 265,322 outputs
Outputs of similar age from Cochrane database of systematic reviews
#20
of 20 outputs
Altmetric has tracked 15,323,046 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 11,168 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 22.9. This one is in the 2nd percentile – i.e., 2% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 265,322 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 18th percentile – i.e., 18% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 20 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.